Herbreteau L, Le Calloch R, Arnaud B, Cassou N, et al. Eculizumab, a real-life successful treatment for refractory cold
agglutinin-mediated auto-immune hemolytic anemia secondary to lymphoproliferative
disorders. Ann Hematol 2021 May 18. pii: 10.1007/s00277-021-04557.
PMID: 34003325